Palliative and hospice care in gynecologic cancer: A review

Gynecologic Oncology

Volumn 131, Issue 1, 2013, Pages 215-221

  Lopez Acevedo, Micael ^a   Lowery, William J ^a   Lowery, Ashlei W ^a   Lee, Paula S ^a,b   Havrilesky, Laura J ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CANCER INSTITUTE   (United States)

Author keywords

Cost; Gynecologic cancer; Healthcare resource utilization; Hospice; Palliative care

Indexed keywords

ANALGESIC AGENT; ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID; DEXAMETHASONE; GABAPENTIN; ONDANSETRON; OPIATE; PALONOSETRON; PROCHLORPERAZINE;

CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; COST EFFECTIVENESS ANALYSIS; ENTEROCUTANEOUS FISTULA; FEMALE; GYNECOLOGIC CANCER; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HOSPICE CARE; HOSPITALIZATION; HUMAN; INTEGRATED HEALTH CARE SYSTEM; INTENSIVE CARE UNIT; LENGTH OF STAY; LIFE EXPECTANCY; MEDICAL EDUCATION; MEDICARE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OVARY CANCER; PATIENT CONTROLLED ANALGESIA; PATIENT REFERRAL; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; REIMBURSEMENT; REVIEW; TERMINAL CARE; TERMINALLY ILL PATIENT;

EID: 84885306749     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.06.012     Document Type: Review

References (69)

1. Wanzer SH, Federman DD, Adelstein SJ, Cassel CK, Cassem EH, Cranford RE, et al. The physician's responsibility toward hopelessly ill patients. A second look. N Engl J Med 1989;320(13): 844-9.
2. Cancer care during the last phase of life. J Clin Oncol 1998;16(5): 1986-96.
3. World Health Assembly: WHA58.22 Cancer Prevention and Control. [Internet]. [cited 2013 Mar 10]. Available from: http://apps.who.int/gb/ebwha/ pdf-files/ WHA58-REC1/english/A58-2005-REC1-en.pdf.
4. American Board of Medical Specialties. [Internet]. [cited 2013 Mar 10]. Available from: http://www.abms.org/Who-We-Help/Physicians/specialties.aspx.
5. Growth of Palliative Care in the U.S. Hospitals 2012 Snapshot. [Internet]. [cited 2013 Mar 10]. Available from: www.capc.org/capc-growth- analysis-snapshot- 2011.pdf.
6. Hui D, Elsayem A, De la Cruz M, Berger A, Zhukovsky DS, Palla S, et al. Availability and integration of palliative care at US cancer centers. JAMA 2010;303(11): 1054-61.
7. National Hospice and Palliative Care Organization. NHPCO Facts and Figures: Hospice Care in America 2011 Edition. [Internet]. [cited 2013 Mar 10]. Available from: http://www.nhpco.org/sites/default/files/public/Statistics- Research/2011- Facts-Figures.pdf.
8. The debate in hospice care. J Oncol Pract 2008;4(3): 153-7.
9. Christakis NA, Iwashyna TJ. Impact of individual and market factors on the timing of initiation of hospice terminal care. Med Care 2000;38(5): 528-41.
10. Rickerson E, Harrold J, Kapo J, Carroll JT, Casarett D. Timing of hospice referral and families' perceptions of services: are earlier hospice referrals better? J Am Geriatr Soc 2005;53(5): 819-23.
11. Goodman DC, Fisher ES, Chang C, Morden NE, Jacobson JO, Murray K, et al. Quality of end-of-life cancer care for medicare beneficiaries regional and hospital-specific analyses. In: Bronner K, editor. A report of the Dartmouth Atlas Project. Dartmouth Institute for Health Policy and Clinical Practice; 2010. p. 1-51.
12. Bruera E, Hui D. Integrating supportive and palliative care in the trajectory of cancer: establishing goals and models of care. J Clin Oncol 2010;28(25): 4013-7.
13. Christakis NA. Timing of referral of terminally ill patients to an outpatient hospice. J Gen Intern Med 1994;9(6): 314-20.
14. Christakis NA, Escarce JJ. Survival of Medicare patients after enrollment in hospice programs. N Engl J Med 1996;335(3): 172-8.
15. Jennings B, Ryndes T, D'Onofrio C, Baily MA. Access to hospice care. Expanding boundaries, overcoming barriers. Hastings Cent Rep 2003(Suppl. S3-7):S9-S13 [S5-21 passim].
16. Carlson MD, Morrison RS, Bradley EH. Improving access to hospice care: informing the debate. J Palliat Med 2008;11(3): 438-43.
17. Rodriguez KL, Barnato AE, Arnold RM. Perceptions and utilization of palliative care services in acute care hospitals. J Palliat Med 2007;10(1): 99-110.
18. Friedman BT, Harwood MK, Shields M. Barriers and enablers to hospice referrals: an expert overview. J Palliat Med 2002;5(1): 73-84.
19. Christakis NA, Lamont EB. Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study. BMJ 2000;320(7233): 469-72.
20. Keating NL, Landrum MB, Rogers Jr SO, Baum SK, Virnig BA, Huskamp HA, et al. Physician factors associated with discussions about end-of-life care. Cancer 2010;116(4): 998-1006.
21. Smith JL. Why do physicians overestimate life expectancy of a person who is terminally ill?: Commentary. West J Med 2000;172(5): 313-4.
22. 2011 Public Opinion Research on Palliative Care: A Report Based on Research by Public Opinion Strategies. [Internet]. [cited 2013 Mar 10]. Available from: http://www.capc.org/tools-for-palliative-care-programs/ marketing/publicopinion- research/2011-public-opinion-research-on-palliative- care.pdf.
23. DesHarnais S, Carter RE, Hennessy W, Kurent JE, Carter C. Lack of concordance between physician and patient: reports on end-of-life care discussions. J Palliat Med 2007;10(3): 728-40.
24. Understanding hospice - an underutilized option for life's final chapter. N Engl J Med 2007;357(4): 321-4.
25. Snow CE, Varela BR, Pardi DA, Adelman RD, Said S, Reid MC. Identifying factors affecting utilization of an inpatient palliative care service: a physician survey. J Palliat Med 2009;12(3): 231-7.
26. Ferris FD, Bruera E, Cherny N, Cummings C, Currow D, Dudgeon D, et al. Palliative cancer care a decade later: accomplishments, the need, next steps - from the American Society of Clinical Oncology. J Clin Oncol 2009;27(18): 3052-8.
27. von Gruenigen VDB, Gibbons H, Hutchins J, Green A. Indicators of survival duration in ovarian cancer and implications for aggressiveness of care. Cancer 2008;112(10): 2221-7.
28. Lopez-Acevedo M, Havrilesky LJ, Broadwater G, Kamal AH, Abernethy AP, Berchuck A, et al. Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer. Gynecol Oncol 2013;130(1): 151-6.
29. Lewin SN, Buttin BM, Powell MA, Gibb RK, Rader JS, Mutch DG, et al. Resource utilization for ovarian cancer patients at the end of life: how much is too much? Gynecol Oncol 2005;99(2): 261-6.
30. Fairfield KM, Murray KM, Wierman HR, Han PK, Hallen S, Miesfeldt S, et al. Disparities in hospice care among older women dying with ovarian cancer. Gynecol Oncol 2012;125(1): 14-8.
31. Fauci J, Schneider K, Walters C, Boone J, Whitworth J, Killian E, et al. The utilization of palliative care in gynecologic oncology patients near the end of life. Gynecol Oncol 2012;127(1): 175-9.
32. Keyser EA, Reed BG, Lowery WJ, Sundborg MJ, Winter III WE, Ward JA, et al. Hospice enrollment for terminally ill patients with gynecologic malignancies: impact on outcomes and interventions. Gynecol Oncol 2010;118(3): 274-7.
33. Ramondetta LM, Tortolero-Luna G, Bodurka DC, Sills D, Basen-Engquist K, Gano J, et al. Approaches for end-of-life care in the field of gynecologic oncology: an exploratory study. Int J Gynecol Cancer 2004;14(4): 580-8.
34. von Gruenigen VE, Daly BJ. Futility: clinical decisions at the end-of-life in women with ovarian cancer. Gynecol Oncol 2005;97(2): 638-44.
35. Smith AK, Earle CC, McCarthy EP. Racial and ethnic differences in end-of-life care in fee-for-service Medicare beneficiaries with advanced cancer. J Am Geriatr Soc 2009;57(1): 153-8.
36. Ngo-Metzger Q, Phillips RS, McCarthy EP. Ethnic disparities in hospice use among Asian-American and Pacific Islander patients dying with cancer. J Am Geriatr Soc 2008;56(1): 139-44.
37. Lesnock JL, Arnold RM, Meyn LA, Buss MK, Quimper M, Krivak TC, et al. Palliative care education in gynecologic oncology: a survey of the fellows. Gynecol Oncol 2013 Sep;130(3): 431-5.
38. Riley GF, Lubitz JD. Long-term trends in Medicare payments in the last year of life. Health Serv Res 2010;45(2): 565-76.
39. National Voluntary Consensus Standards for Quality of Cancer Care. [Internet]. [cited 2013 Mar 10]. Available from: http://www.qualityforum.org/ Publications/2009/05/ National-Voluntary-Consensus-Standards-for-Quality-of- Cancer-Care.aspx.
40. Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 2004;22(2): 315-21.
41. Barbera L, Elit L, Krzyzanowska M, Saskin R, Bierman AS. End of life care for women with gynecologic cancers. Gynecol Oncol 2010;118(2): 196-201.
42. Levy MH, Back A, Bazargan S, Benedetti C, Billings JA, Block S, et al. Palliative care. Clinical practice guidelines in oncology. J Natl Compr Canc Netw2006;4(8): 776-818.
43. Levy MH, Back A, Benedetti C, Billings JA, Block S, Boston B, et al. NCCN clinical practice guidelines in oncology: palliative care. J Natl Compr Canc Netw 2009;7(4): 436-73.
44. Teno JM, Clarridge BR, Casey V, Welch LC, Wetle T, Shield R, et al. Family perspectives on end-of-life care at the last place of care. JAMA 2004;291(1): 88-93.
45. Higginson IJ, Finlay IG, Goodwin DM, Hood K, Edwards AG, Cook A, et al. Is there evidence that palliative care teams alter end-of-life experiences of patients and their caregivers? J Pain Symptom Manage 2003;25(2): 150-68.
46. Penrod JD, Deb P, Luhrs C, Dellenbaugh C, Zhu CW, Hochman T, et al. Cost and utilization outcomes of patients receiving hospital-based palliative care consultation. J Palliat Med 2006;9(4): 855-60.
47. Ciemins EL, Blum L, Nunley M, Lasher A, Newman JM. The economic and clinical impact of an inpatient palliative care consultation service: a multifaceted approach. J Palliat Med 2007;10(6): 1347-55.
48. Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010;363(8): 733-42.
49. Hearn J, Higginson IJ. Do specialist palliative care teams improve outcomes for cancer patients? A systematic literature review. Palliat Med 1998;12(5): 317-32.
50. Bakitas M, Lyons KD, Hegel MT, Balan S, Barnett KN, Brokaw FC, et al. The project ENABLE II randomized controlled trial to improve palliative care for rural patients with advanced cancer: baseline findings, methodological challenges, and solutions. Palliat Support Care 2009;7(1): 75-86.
51. Wenzel L, Huang HQ, Monk BJ, Rose PG, Cella D. Quality-of-life comparisons in a randomized trial of interval secondary cytoreduction in advanced ovarian carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 2005;23(24): 5605-12.
52. Wenzel L, Berkowitz RS, Habbal R, Newlands E, Hancock B, Goldstein DP, et al. Predictors of quality of life among long-term survivors of gestational trophoblastic disease. J Reprod Med 2004;49(8): 589-94.
53. von Gruenigen VE, Huang HQ, Gil KM, Frasure HE, Armstrong DK, Wenzel LB. The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: a Gynecologic Oncology Group Study. Gynecol Oncol 2012;124(3): 379-82.
54. Congressional Office Budget. [Internet]. [cited 2013 Mar 10]. Available from: cbo.gov/topics/health-care/cost-estimates.
55. Emanuel EJ, Ash A, Yu W, Gazelle G, Levinsky NG, Saynina O, et al. Managed care, hospice use, site of death, and medical expenditures in the last year of life. Arch Intern Med 2002;162(15): 1722-8.
56. Curtis JR, Engelberg RA, Bensink ME, Ramsey SD. End-of-life care in the intensive care unit: can we simultaneously increase quality and reduce costs? Am J Respir Crit Care Med 2012;186(7): 587-92.
57. Smith TJ, Cassel JB. Cost and non-clinical outcomes of palliative care. J Pain Symptom Manage 2009;38(1): 32-44.
58. Morrison RS, Dietrich J, Ladwig S, Quill T, Sacco J, Tangeman J, et al. Palliative care consultation teams cut hospital costs for Medicaid beneficiaries. Health Aff (Millwood) 2011;30(3): 454-63.
59. Morrison RS, Penrod JD, Cassel JB, Caust-Ellenbogen M, Litke A, Spragens L, et al. Cost savings associated with US hospital palliative care consultation programs. Arch Intern Med 2008;168(16): 1783-90.
60. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977;296(13): 716-21.
61. Sfakianos GP, Havrilesky LJ. A review of cost-effectiveness studies in ovarian cancer. Cancer Control 2011;18(1): 59-64.
62. Rocconi RP, Case AS, Straughn Jr JM, Estes JM, Partridge EE. Role of chemotherapy for patients with recurrent platinum-resistant advanced epithelial ovarian cancer: a cost-effectiveness analysis. Cancer 2006;107(3): 536-43.
63. Lowery WJ, Lowery AW, Barnett JC, Lopez MA, Lee PS, Secord AA, et al. Cost effectiveness of early palliative care intervention in recurrent platinum-resistant ovarian cancer. Gynecol Oncol Jun 2013. http://dx.doi.org/10. 1016/j.ygyno.2013.06.011 [pii: S0090-8258(13)00844-5, PMID: 23769759] [Electronic publication ahead of print].
64. Bakitas M, Lyons KD, Hegel MT, Balan S, Brokaw FC, Seville J, et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA 2009;302(7): 741-9.
65. Gade G, Venohr I, Conner D,McGrady K, Beane J, Richardson RH, et al. Impact of an inpatient palliative care team: a randomized control trial. J Palliat Med 2008;2: 180-90.
66. Meyers FJ, Carducci M, Loscalzo MJ, Linder J, Greasby T, Beckett LA. Effects of a problem-solving intervention (COPE) on quality of life for patients with advanced cancer on clinical trials and their caregivers: simultaneous care educational intervention (SCEI): linking palliation and clinical trials. J Palliat Med 2011;14(4): 465-73.
67. Pantilat SZ, O'Riordan DL, Dibble SL, Landefeld CS. Hospital-based palliative medicine consultation: a randomized controlled trial. Arch Intern Med 2010;170(22): 2038-40.
68. Rabow MW, Dibble SL, Pantilat SZ, McPhee SJ. The comprehensive care team: a controlled trial of outpatient palliative medicine consultation. Arch Intern Med 2004;164(1): 83-91.
69. Smith TJ, Temin S, Alesi ER, Abernethy AP, Balboni TA, Basch EM, et al. American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 2012;30(8): 880-7.